01 Nov 2011
Exposure to compounds that antagonise steroid hormones can disrupt endocrine functions and modulate susceptibility to cancer. Anti-androgenic drugs are used to treat prostate cancer, but clinical responses sometimes improve after anti-androgen treatment is stopped. Anti-androgens can exert powerful effects during development that increase susceptibility of both exposed experimental animals and their descendants to a range of chronic diseases, including prostatic disease. The aim of this project is to elucidate the effects of anti-androgens on the epigenome and transcriptome during development of the zebrafish, a model vertebrate, and in human prostate cancer cells.
Interested candidates should contact the project supervisor Vincent Cunliffe at [email protected]. Click on the link below for eligibility criteria and details of how to apply. The closing date for applications is 22 November 2011.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024